Protected: Media Kit

This content is password protected. To view it please enter your password below:

1 in 3 people with heart failure have Central Sleep Apnea and stop breathing during the night. Talk to your doctor about the remedē® System clinical study to see if you qualify.
Send us an email at or read about our clinical study at


Respicardia®, Inc.
12400 Whitewater Dr., Suite 150
Minnetonka, MN 55343 USA
See Map
Phone: +1-952-540-4470
©2017 Respicardia®, Inc. CAUTION: Investigational Device. Limited by Federal (or United States) Law to investigational use.